Noreen Henig
CIK 1810995 · View on SEC EDGAR ↗
First SEC filing: June 11, 2020 · Latest: June 11, 2020
On this page
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | RNA | D | 9,534 | — | — | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 11,323 | — | — | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 15,000 | — | — | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 22,000 | — | — | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 22,000 | — | — | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 13,489 | — | — | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 10,034 | — | — | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 6,692 | — | — | 0 Direct | -100.00% | Disposed | |
| June 15, 2022 | RNA | A | 22,000 | — | — | 22,000 Direct | — | Acquired | |
| June 16, 2021 | RNA | A | 15,000 | — | — | 15,000 Direct | — | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (9,534) | $0.42 | Aug. 27, 2029 | 9,534 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (11,323) | $8.82 | May 14, 2030 | 11,323 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (15,000) | $26.09 | June 15, 2031 | 15,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (22,000) | $12.03 | June 14, 2032 | 22,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (22,000) | $12.48 | June 14, 2033 | 22,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (13,489) | $39.96 | June 12, 2034 | 13,489 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock (10,034) | $33.62 | June 9, 2035 | 10,034 | Disposed |
| June 15, 2022 | RNA | Stock Option (Right to Buy) | Common Stock (22,000) | $12.03 | June 14, 2032 | 22,000 | Acquired |
| June 16, 2021 | RNA | Stock Option (Right to Buy) | Common Stock (15,000) | $26.09 | June 15, 2031 | 15,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 11, 2020 | RNA | Stock Option (Right to Buy)→ Common Stock (11,323) | 11,323 | Direct |
| June 11, 2020 | RNA | Stock Option (Right to Buy)→ Common Stock (9,534) | 9,534 | Direct |